Research & Training Funding

The Ontario Institute for Regenerative Medicine (OIRM) and the Centre for Commercialization of Cancer Immunotherapy and Regenerative Medicine (C3i) are on a mission to make it easier for Ontario’s regenerative medicine (RM) sector to thrive. OIRM and C3i are partnering with the BioInnovation Fund, Bloom Burton & Co., Ontario Bioscience Innovation Organization and Versant Ventures to ensure these made-in-Ontario technologies get the strategic support they need to succeed.

Kick-Start will support successful applicants with resources to create an incorporated business, along with market assessments and an IP/commercialization plan. Investment funding of up to $100,000 and expert guidance from partners will help researcher attract early-stage investment and build value for the new company. The program will also link applicants with investors and other private sector expertise needed to attract funding and to develop and market the proposed technology.

Click here to download the Kick Start Innovation Investment Program summary PDF (displayed below).

Click here to download the Kick Start NOI template (Word file).

Oct 23, 2020 Fast Five: Meet Dr. Vince Tropepe

Oct 23, 2020 Cell Therapy Seeks to Undo “Irreversible” Scarring After a Heart Attack

Oct 14, 2020 Fast Five: Meet Dr. Derek van der Kooy

Oct 13, 2020 Muscling in on a Devasting Disease

Oct 01, 2020 Fast Five: Meet Dr. Emilio Alarcon

Sep 28, 2020 Second Lives

Aug 26, 2020 Solving a Burning Question

Jul 28, 2020 Strategic Alliance a Shot in the Arm for Stem Cell Commercialization Efforts

Jul 07, 2020 Incubating Big Ideas

May 27, 2020 Experimental Stem Cell Therapy a Potential Weapon in COVID-19 Fight